Everest Organics has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 13, 2024, to consider and approve the un-audited Financial Results of the Company for the quarter ended June 30, 2024. Further, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, read with Company's ‘Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relatives of Designated Persons’, the trading window shall remain closed from 01st July, 2024 and will re-open after 48 hours (i.e., 15th August, 2024) of the declaration of the financial results of the company for the quarter ended 30th June, 2024.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1837.15 |
| Dr. Reddys Lab | 1271.55 |
| Cipla | 1353.85 |
| Zydus Lifesciences | 1070.90 |
| Lupin | 2351.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: